Kite Lake Capital Management (UK) LLP Buys China Biologic Products Holdings Inc, Qiagen NV, Sells WABCO Holdings Inc, Spark Therapeutics Inc, Versum Materials Inc

Author's Avatar
[email protected]
Mar 10, 2020
Article's Main Image
Investment company Kite Lake Capital Management (UK) LLP (Current Portfolio) buys China Biologic Products Holdings Inc, Qiagen NV, sells WABCO Holdings Inc, Spark Therapeutics Inc, Versum Materials Inc, Pacific Biosciences of California Inc, Pivotal Software Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Kite Lake Capital Management (UK) LLP. As of 2019Q4, Kite Lake Capital Management (UK) LLP owns 3 stocks with a total value of $32 million. These are the details of the buys and sells.

For the details of Kite Lake Capital Management (UK) LLP's stock buys and sells, go to https://www.gurufocus.com/guru/kite+lake+capital+management+%28uk%29+llp/current-portfolio/portfolio

These are the top 5 holdings of Kite Lake Capital Management (UK) LLP
  1. China Biologic Products Holdings Inc (CBPO) - 207,382 shares, 76.46% of the total portfolio. Shares added by 72.00%
  2. Qiagen NV (QGEN) - 180,455 shares, 19.32% of the total portfolio. New Position
  3. Bristol-Myers Squibb Company RIGHTS (BMY.R) - 442,340 shares, 4.22% of the total portfolio. New Position
  4. Versum Materials Inc (VSM) - 0 shares, 0.00% of the total portfolio. Shares reduced by 10000%
  5. Spark Therapeutics Inc (ONCE) - 0 shares, 0.00% of the total portfolio. Shares reduced by 10000%
New Purchase: Qiagen NV (QGEN)

Kite Lake Capital Management (UK) LLP initiated holding in Qiagen NV. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $41.44. The impact to a portfolio due to this purchase was 19.32%. The holding were 180,455 shares as of .

Added: China Biologic Products Holdings Inc (CBPO)

Kite Lake Capital Management (UK) LLP added to a holding in China Biologic Products Holdings Inc by 72.00%. The purchase prices were between $113 and $117.14, with an estimated average price of $115.84. The stock is now traded at around $115.95. The impact to a portfolio due to this purchase was 32.01%. The holding were 207,382 shares as of .

Sold Out: WABCO Holdings Inc (WBC)

Kite Lake Capital Management (UK) LLP sold out a holding in WABCO Holdings Inc. The sale prices were between $134.18 and $135.52, with an estimated average price of $134.85.

Sold Out: Spark Therapeutics Inc (ONCE)

Kite Lake Capital Management (UK) LLP sold out a holding in Spark Therapeutics Inc. The sale prices were between $96.25 and $113.57, with an estimated average price of $107.51.

Sold Out: Versum Materials Inc (VSM)

Kite Lake Capital Management (UK) LLP sold out a holding in Versum Materials Inc. The sale prices were between $52.97 and $52.99, with an estimated average price of $52.98.

Sold Out: Pacific Biosciences of California Inc (PACB)

Kite Lake Capital Management (UK) LLP sold out a holding in Pacific Biosciences of California Inc. The sale prices were between $4.6 and $5.57, with an estimated average price of $5.08.

Sold Out: Pivotal Software Inc (PVTL)

Kite Lake Capital Management (UK) LLP sold out a holding in Pivotal Software Inc. The sale prices were between $14.89 and $15.05, with an estimated average price of $14.98.

Sold Out: Genesee & Wyoming Inc (GWR)

Kite Lake Capital Management (UK) LLP sold out a holding in Genesee & Wyoming Inc. The sale prices were between $110.16 and $111.94, with an estimated average price of $111.13.



Here is the complete portfolio of Kite Lake Capital Management (UK) LLP. Also check out:

1. Kite Lake Capital Management (UK) LLP's Undervalued Stocks
2. Kite Lake Capital Management (UK) LLP's Top Growth Companies, and
3. Kite Lake Capital Management (UK) LLP's High Yield stocks
4. Stocks that Kite Lake Capital Management (UK) LLP keeps buying
Rating:
0 / 5 (0 votes)